Data / Form D filings / GLYCOMIMETICS INC
GLYCOMIMETICS INC: Form D filings
GLYCOMIMETICS INC, a pharmaceuticals company in Gaithersburg, MD, filed 3 Form D notices with the SEC between 2009 and 2010. The latest, on October 27, 2010, reports $39 million sold of a $50 million offering to 15 investors.
Find out what GLYCOMIMETICS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 101 Orchard Ridge Drive, Suite 1E, Gaithersburg, MD, 20878
- Phone
- (240) 243-1201
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1253689
The full lists. Form D filings in Maryland: 608 rows, $30.40, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 27, 2010 | Amendment | $50,000,000 | $38,979,412 | $11,020,588 | 15 | Oct 20, 2009 | sec.gov |
| Nov 4, 2009 | New notice | $15,315,525 | $15,315,525 | $0 | 10 | Jul 3, 2008 | sec.gov |
| Nov 4, 2009 | New notice | $50,000,000 | $38,979,412 | $11,020,588 | 15 | Oct 20, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| M. James Barrett | Director | |
| Michael James Henos | Director | |
| Franklin James Top | Director | |
| Helen Thackray | Executive Officer | |
| Rachel King | Executive Officer, Director | |
| John Magnani | Executive Officer, Director | |
| John James Baldwin | Director | |
| William James Gust | Director |
Every Form D from the week of Oct 25, 2010 · All recent filings in Maryland · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what GLYCOMIMETICS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.